Shares of Charles River Laboratories International Inc. CRL shed 1.91% to $161.62 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX ...

Charles River Laboratories International, Inc. CRL is scheduled to report fourth-quarter 2024 results on Feb.19, before ...

In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...

Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, indicating future capital deployment.

Flagship Harbor Advisors LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) ...

The company told state officials that it plans to initially lay off at least 31 employees as it works to close its Pathology Associates International office on Stirrup Creek Drive.

The outlook for Wilmington, Massachusetts-based contract research organization (CRO) Charles River Laboratories International ...

Upslope Capital Management, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the ...

Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities research analysts at William ...

STORY HIGHLIGHTS Charles River Laboratories is closing facilities in Durham and Research Triangle Park. The company will lay off 31 employees at its Durham facility. Charles River expects revenue ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call ...